Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer
- PMID: 17342202
- PMCID: PMC1800910
- DOI: 10.1371/journal.pone.0000268
Tagging single nucleotide polymorphisms in the BRIP1 gene and susceptibility to breast and ovarian cancer
Abstract
Background: BRIP1 interacts with BRCA1 and functions in regulating DNA double strand break repair pathways. Germline BRIP1 mutations are associated with breast cancer and Fanconi anemia. Thus, common variants in the BRIP1 are candidates for breast and ovarian cancer susceptibility.
Methods: We used a SNP tagging approach to evaluate the association between common variants (minor allele frequency>or=0.05) in BRIP1 and the risks of breast cancer and invasive ovarian cancer. 12 tagging SNPs (tSNPs) in the gene were identified and genotyped in up to 2,270 breast cancer cases and 2,280 controls from the UK and up to 1,513 invasive ovarian cancer cases and 2,515 controls from the UK, Denmark and USA. Genotype frequencies in cases and controls were compared using logistic regression.
Results: Two tSNPs showed a marginal significant association with ovarian cancer: Carriers of the minor allele of rs2191249 were at reduced risk compared with the common homozygotes (Odds Ratio (OR) = 0.90 (95% CI, 0.82-1.0), P-trend = 0.045) and the minor allele of rs4988344 was associated with increased risk (OR = 1.15 (95%CI, 1.02-1.30), P-trend = 0.02). When the analyses were restricted to serous ovarian cancers, these effects became slightly stronger. These results were not significant at the 5% level after adjusting for multiple testing. None of the tSNPs was associated with breast cancer.
Conclusions: It is unlikely that common variants in BRIP1 contribute significantly to breast cancer susceptibility. The possible association of rs2191249 and rs4988344 with ovarian cancer risks warrant confirmation in independent case-control studies.
Conflict of interest statement
Figures

Similar articles
-
BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.Breast Cancer Res. 2018 Jan 24;20(1):7. doi: 10.1186/s13058-018-0935-9. Breast Cancer Res. 2018. PMID: 29368626 Free PMC article.
-
Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.Hum Mutat. 2003 Aug;22(2):121-8. doi: 10.1002/humu.10238. Hum Mutat. 2003. PMID: 12872252
-
Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.BMC Cancer. 2006 Sep 29;6:230. doi: 10.1186/1471-2407-6-230. BMC Cancer. 2006. PMID: 17010193 Free PMC article.
-
BRIP1, a potential candidate gene in development of non-BRCA1/2 breast cancer.Front Biosci (Elite Ed). 2016 Jan 1;8(2):289-98. doi: 10.2741/E767. Front Biosci (Elite Ed). 2016. PMID: 26709662 Review.
-
BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature.BMC Med Genet. 2019 May 7;20(1):75. doi: 10.1186/s12881-019-0812-0. BMC Med Genet. 2019. PMID: 31064327 Free PMC article. Review.
Cited by
-
Association of Single-Nucleotide Polymorphisms in Monoubiquitinated FANCD2-DNA Damage Repair Pathway Genes With Breast Cancer in the Chinese Population.Technol Cancer Res Treat. 2018 Jan 1;17:1533033818819841. doi: 10.1177/1533033818819841. Technol Cancer Res Treat. 2018. PMID: 30799775 Free PMC article.
-
Correlation of the BACH1 Pro919Ser polymorphism with breast cancer risk: A literature-based meta-analysis and meta-regression analysis.Exp Ther Med. 2013 Aug;6(2):435-444. doi: 10.3892/etm.2013.1148. Epub 2013 Jun 7. Exp Ther Med. 2013. PMID: 24137204 Free PMC article.
-
BRIP1 overexpression is correlated with clinical features and survival outcome of luminal breast cancer subtypes.Endocr Connect. 2018 Jan;7(1):65-77. doi: 10.1530/EC-17-0173. Epub 2017 Nov 14. Endocr Connect. 2018. PMID: 29138235 Free PMC article.
-
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.Br J Cancer. 2009 Mar 24;100(6):993-1001. doi: 10.1038/sj.bjc.6604947. Epub 2009 Feb 24. Br J Cancer. 2009. PMID: 19240718 Free PMC article.
-
Male Breast Cancer With Dual BRCA2 and BRIP1 Deleterious Gene Mutations.Ochsner J. 2024 Summer;24(2):157-161. doi: 10.31486/toj.23.0119. Ochsner J. 2024. PMID: 38912178 Free PMC article.
References
-
- Lynch HT, Casey MJ, Lynch J, White TE, Godwin AK. Genetics and ovarian carcinoma. Semin.Oncol, 1998;25:265–280. - PubMed
-
- Rahman N, Stratton MR. The genetics of breast cancer susceptibility. Annu Rev Genet, 1998;32:95–121. - PubMed
-
- Pharoah PD, Ponder BA. The genetics of ovarian cancer. Best Pract.Res Clin Obstet Gynaecol., 2002;16:449–468. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous